Merck & Co. Inc. (NYSE:MRK): According to Credit Suisse, investors underestimate Merk’s pipeline and valuation is attractive. The firm gives an Outperform rating on the shares.
Investing Insights: HEALTHY Drug Stocks Offering a Prescription for Stock Market PAIN.
Ryder System, Inc. (NYSE:R) has its price target dropped by Jeffries following the company’s Q2 below census guidance, but the firm says the updated outlook may have “cleared the decks. The firm maintains a Buy rating on the stock.
Las Vegas Sands Corp. (NYSE:LVS): As a result of softness in Macau gaming revenues as well as China’s macro slowdown, Bank of America Merrill Lynch has dropped the Buy ratings for Las Vegas Sands (NYSE:LVS) and Wynn Resorts (NASDAQ:WYNN). Also, Las Vegas Sands’ price target was reduced to $60 from $65 and Wynn’s was lowered to $130 from $140.
Valeant Pharmaceuticals International (NYSE:VRX): Jefferies views Valeant’s analyst day yesterday as a success. The firm notes that the company reaffirmed the upper end of its earnings guidance even though the company had more than 20% European exposure. The firm maintains its Buy rating but reduces its price target from $75 to $63 on the stock.
Eagle Bulk Shipping, Inc. (NASDAQ:EGLE): According to global Hunter, a selling opportunity has been created by strength in regards to Eagle Bulk Shipping’s agreement with lenders in order to amend its credit facility. The firm adds that the deal will raise interest expense and existing shareholder value will be reduced because of the warrants. The firm intends for cash flow to assist in paying debt. The firm gives a Reduced rating and a $3 price target on the stock.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.